Topic

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

Articles

Achieving herd immunity will require testing, data, a vaccine, and public support. 

Are We All In This Together?

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Pharma’s reputation is being boosted in light of the current COVID-19 pandemic efforts.

A Little More Respect

Dr. Reddy Gottipolu is SVP Healthcare at One Network Enterprises, provider of an AI-enabled business network platform that enables all trading partners to manage, optimize and automate complex business processes in real time.

A network-based supply chain approach has the potential to improve resilience and performance.

New Resilience: How COVID-19 Delivered the Ultimate Stress Test for Pharma Supply Chains

Will moving at “warp speed” to develop a vaccine impact efficacy or safety?

How Fast Is Too Fast?

Siegfried Schmitt, PhD, is Vice President Technical at Parexel International, Siegfried.Schmitt@parexel.com.

Having a better understanding about compliance will be of benefit when looking for a job or for furthering one’s career, says Siegfried Schmitt, PhD, vice-president, technical, Parexel Consulting.


Starting a Career in the Bio/Pharmaceutical Industry

In light of the hype around chloroquine and hydroxychloroquine as potential COVID-19 treatments, it is important to remember that drug repurposing should never be rushed, irrespective of the urgency of the situation.

Can We Teach an Old Drug New Tricks?

George I’ons is head of Product Strategy and Insights, Owen Mumford Pharmaceutical Services.

Industry opportunities are increasing for biosimilars, but companies should pay close attention to delivery device design to facilitate success.


The Design Driver for Biosimilar Adoption

Characterizing and controlling protein aggregation is vital to ensure safety and efficacy of a biopharmaceutical product. In this interview, important aspects of protein aggregation and the tools available to address this issue are discussed.


Keeping Aggregation Under Control

As the coronavirus pandemic unfolds, Pharma must practice science over hype.

Pharma’s Leadership Role in a Pandemic

According to recent figures, Cambridge’s technology sector is booming and the city is emerging as a hub for biotech companies.

Viewpoints